Hyaluronidase

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 6 USDMF, 3 CEP/COS, 2 JDMF, 6 KDMF, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 5 FDA Orange Book, 1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 6 Seppic

EXCIPIENTS BY APPLICATIONS

14 Parenteral, 10 Solubilizers, 4 Topical, 3 Film Formers & Plasticizers, 3 Emulsifying Agents, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Fillers, Diluents & Binders, 1 Coating Systems & Additives, 1 Taste Masking, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

3 Annual Reports

MARKET PLACE

9 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

2 EDQM

$ Xls

Filters

Also known as: 88755-39-9, Chembl2000337, Runx1/eto tetramerization-in-1, Nsc162496, Schembl16211954, Dtxsid40864143

Molecular Formula

C₁₈H₁₄O₇

Molecular Weight

342.3 g/mol

InChI Key

PPEBBOHQEAQKSW-UHFFFAOYSA-N

1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2,4-bis(1,3-benzodioxol-5-yl)-4-oxobutanoic acid

2.1.2 InChI

InChI=1S/C18H14O7/c19-13(11-2-4-15-17(6-11)25-9-23-15)7-12(18(20)21)10-1-3-14-16(5-10)24-8-22-14/h1-6,12H,7-9H2,(H,20,21)

2.1.3 InChI Key

PPEBBOHQEAQKSW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1OC2=C(O1)C=C(C=C2)C(CC(=O)C3=CC4=C(C=C3)OCO4)C(=O)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 88755-39-9

2. Chembl2000337

3. Runx1/eto Tetramerization-in-1

4. Nsc162496

5. Schembl16211954

6. Dtxsid40864143

7. Bdbm50392853

8. 2,3]dioxol-5-yl)-4-oxobutanoic Acid

9. Nsc-162496

10. Hy-151411

11. Cs-0611487

12. Ft-0627100

13. A937131

14. Butanoic Acid,4-bis[1,3-benzodioxol-5-yl]-4-oxo-

15. 2,4-bis(2h-1,3-benzodioxol-5-yl)-4-oxobutanoic Acid

2.3 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₄O₇
Molecular Weight	342.3 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	5
Exact Mass	342.07395278 g/mol
Monoisotopic Mass	342.07395278 g/mol
Topological Polar Surface Area	91.3 Å²
Heavy Atom Count	25
Formal Charge	0
Complexity	522
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Hyaluronidase

Hyaluronidase

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

6 USDMF

3 CEP/COS

2 JDMF

6 KDMF

1 NDC API

2 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers

5 FDA Orange Book

1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Actylis

1 BASF

1 Finar

4 Gangwal Chemicals

1 Kerry

1 Microlex e.U

1 Nanjing Bold Chemical

1 Pluviaendo

6 Seppic

EXCIPIENTS BY APPLICATIONS

14 Parenteral

10 Solubilizers

4 Topical

3 Film Formers & Plasticizers

3 Emulsifying Agents

2 Surfactant & Foaming Agents

2 Thickeners and Stabilizers

1 Controlled & Modified Release

1 Direct Compression

1 Co-Processed Excipients

1 Rheology Modifiers

1 Fillers, Diluents & Binders

1 Coating Systems & Additives

1 Taste Masking

1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

MARKET PLACE

9 APIs

3 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

Filters